Evidence map›Paper›PMID 38589671›Full record

ArticleGeroScience2024

Reduced insulin/IGF-1 signalling upregulates two anti-viral immune pathways, decreases viral load and increases survival under viral infection in C. elegans.

Elizabeth M L Duxbury, Hanne Carlsson, Annabel Kimberley, Yvonne Ridge, Katie Johnson, Alexei A Maklakov

Abstract read
In one paragraph

Article in GeroScience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Unzipping the defense: a comprehensive review on bZIP transcription factors inFrontiers in cellular and infection microbiology · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Elizabeth M L DuxburySchool of Biological Sciences, University of East Anglia, Norwich, UK. E.Duxbury@uea.ac.uk.ORCID 0000-0002-5733-3645
Hanne CarlssonSchool of Biological Sciences, University of East Anglia, Norwich, UK.
Annabel KimberleySchool of Biological Sciences, University of East Anglia, Norwich, UK.
Yvonne RidgeSchool of Biological Sciences, University of East Anglia, Norwich, UK.
Katie JohnsonSchool of Biological Sciences, University of East Anglia, Norwich, UK.
Alexei A MaklakovSchool of Biological Sciences, University of East Anglia, Norwich, UK.

Funding

H2020 European Research Council ERC Consolidator Grant (GermlineAgeingSoma/724909)
6 · The paper itself

Abstract

Reduced insulin/IGF-1 signalling (rIIS) improves survival across diverse taxa and there is a growing interest in its role in regulating immune function. Whilst rIIS can improve anti-bacterial resistance, the consequences for anti-viral immunity are yet to be systematically examined. Here, we show that rIIS in adult Caenorhabditis elegans increases the expression of key genes in two different anti-viral immunity pathways, whilst reducing viral load in old age, increasing survival and reducing rate-of-senescence under infection by naturally occurring positive-sense single-stranded RNA Orsay virus. We found that both drh-1 in the anti-viral RNA interference (RNAi) pathway and cde-1 in the terminal uridylation-based degradation of viral RNA pathway were upregulated in early adulthood under rIIS and increased anti-viral resistance was not associated with reproductive costs. Remarkably, rIIS increased anti-viral gene expression only in infected worms, potentially to curb the costs of constitutively upregulated immunity. RNA viruses are found across taxa from plants to mammals and we demonstrate a novel role for rIIS in regulating resistance to viral infection. We therefore highlight this evolutionarily conserved signalling pathway as a promising therapeutic target to improve anti-viral immunity.

Indexed as

Caenorhabditis elegansInsulinInsulin-Like Growth Factor ISignal TransductionUp-RegulationViral LoadAnimalsCaenorhabditis elegans ProteinsCell Cycle ProteinsDEAD-box RNA HelicasesReceptor, InsulinRNA InterferenceCaenorhabditis elegans ProteinsCell Cycle ProteinsCID-1 protein, C elegansDAF-2 protein, C elegansDEAD-box RNA HelicasesDRH-1 protein, C elegansInsulinInsulin-Like Growth Factor IReceptor, InsulinAnti-viral immunityHealthy agingInsulin signallingOrsay RNA virusRate-of-senescence

Identifiers

PMID38589671
PMCPMC11493891

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.